Isotope-Labeled Compounds

PDF 37.01 MB

Isotope-labeled compounds are chemical substances in which some atoms in their molecules are replaced by isotope atoms. The range of stable isotope products can cover from gases to complex molecules. Isotope-labeled compounds could provide a site-specific investigation of structures, making molecules easily detectable by mass spectrometry and NMR, and maintaining the physico-chemical properties of the target molecule at the same time.

MCE isotope-labeled compounds are all stable isotope-labeled compounds and are non-radioactive labeled substances. MCE isotope-labeled compounds are unique tools for identifying and understanding biological and chemical processes. Stable isotope-labeled products are now getting more and more popular among scientists. The scope of application is gradually penetrating into various scientific fields, such as life sciences, food and medicine, agriculture, environment, geology, etc. Stable isotope-labeled compounds have a wide range of applications in the Life Science areas, such as Metabolomics, Proteomics, Clinical studies, Deuterium drugs, etc.

Isotope-Labeled Compounds (12439):

Cat. No.	Product Name	CAS No.	Purity	Chemical Structure

HY-145490S1

trans-Hydroxy Glimepiride-d4	2749985-37-1	98%
trans-Hydroxy Glimepiride-d₄ is deuterium labeled trans-Hydroxy Glimepiride.

HY-146836S2

(Rac)-16:0 PI(5)P-d5 diammonium		99.0%
(Rac)-16:0 PI(5)P-d₅ diammonium is deuterium labeled (Rac)-16:0 PI(5)P diammonium.

HY-146841S1

(Rac)-Lysophosphatidylcholine C19:0-d5		98%
(Rac)-19:0 Lyso PC-d₅ is the deuterium labeled (Rac)-19:0 Lyso PC.

HY-146986S1

N-acetyl-D-talosamine-13C	875654-29-8	98%
N-acetyl-D-talosamine-¹³C is the ¹³C labeled N-acetyl-D-talosamine.

HY-146994S1

L-Idose-13C-1		98%
L-Idose-¹³C-1 is the ¹³C labeled L-Idose.

HY-146994S2

L-Idose-13C-2	115973-80-3	98%
L-Idose-¹³C-2 is the ¹³C labeled L-Idose.

HY-146995S1

Glycolaldehyde-2-13C	478529-67-8	99.3%
Glycolaldehyde-2-¹³C is the ¹³C labeled Glycolaldehyde.

HY-147338S2

5-Methylcytidine 5′-triphosphate-d8 trisodium		98%
5-Methylcytidine 5'-triphosphate-d₈ trisodium is the deuterium-labeled form of 5-Methylcytidine 5'-triphosphate trisodium (HY-147338A). 5-Methylcytidine 5'-triphosphate (5-Methyl-CTP) trisodium is a modified nucleoside triphosphate. 5-Methylcytidine 5'-triphosphate trisodium can be used to replace unmodified mRNA, resulting in the increase of translational properties and stability, as well as the reduction of innate immune responses in human and other mammalian cells.

HY-14749AS1

Pyronaridine-13C2,d4 tetraphosphate		98%
Pyronaridine tetraphosphate-¹³C₂,d₄ is the deuterium and ¹³C-labeled Pyronaridine tetraphosphate (HY-14749A). Pyronaridine tetraphosphate is an orally active Mannich base anti-malarial agent. Pyronaridine tetraphosphate is active against P. falciparum and Echinococcus granulosus infection.

HY-148682S1

18β-Glycyrrhetyl-3-O-sulfate-d2		98%
18β-Glycyrrhetyl-3-O-sulfate-d₂ is the deuterium labeled 18β-Glycyrrhetyl-3-O-sulfate (HY-148682).

HY-151930S1

8′-Hydroxy ABA-d2		98%
8′-Hydroxy ABA-d₂ is the deuterium labeled 8’-Hydroxy ABA.

HY-152070S1

Demethylmaprotiline-d2-1		98%
Demethylmaprotiline-d₂-1 is the deuterium labeled Demethylmaprotiline.

HY-15283AS1

(±)-Clopidogrel-d4	1219274-95-9
(±)-Clopidogrel-d₄ ((±)-Clopidogrelum-d₄) is the deuterium labeled (±)-Clopidogrel (HY-107867). (±)-Clopidogrel is a platelet P2Y12 receptor inhibitor and an adenosine diphosphate (ADP) receptor antagonist. (±)-Clopidogrel inhibits the binding of ADP to its receptors on the membranes of platelet cells, and blocks ADP-mediated activation of the glycoprotein GPIIb/IIIa complex. (±)-Clopidogrel reduces vascular inflammation and angiotensin II induced-abdominal aortic aneurysm progression. (±)-Clopidogrel has anti-inflammatory effects.

HY-156341S1

LLIYYTSSLHSGVPSR-(Arg-13C6,15N4) TFA		98%
LLIYYTSSLHSGVPSR-(Arg-¹³C₆,¹⁵N₄) (TFA) is the peptide containing ¹³C- and ¹⁵N-labeled Arg.

HY-156343S1

SNNYATHYAESVK-(Lys-13C6,15N2) TFA		98%
SNNYATHYAESVK-(Lys-¹³C₆,¹⁵N₂) (TFA) is the peptide containing ¹³C- and ¹⁵N-labeled Lys.

HY-156344S1

GLEWVAEIR-(Arg-13C6,15N4) TFA		98%
GLEWVAEIR-(Arg-¹³C₆,¹⁵N₄) (TFA) is the peptide containing ¹³C- and ¹⁵N-labeled Arg.

HY-156345S1

LPFTFGQGTK-(Lys-13C6,15N2) TFA		98%
LPFTFGQGTK-(Lys-¹³C₆,¹⁵N₂) TFA is the peptide containing ¹³C- and ¹⁵N-labeled Lys.

HY-16168AS1

Degarelix-d7 TFA
Degarelix-d₇ TFA (FE 200486-d₇ TFA) is the deuterium labeled Degarelix TFA. Degarelix acetate (FE 200486) is a decapeptide that shows high affinity/selectivity to human gonadotropin-releasing hormone (GnRH) receptor (IC₅₀ = 3 nM). Degarelix acetate Degarelix acetate (FE 200486) is used for the research of prostate cancer.

HY-16168AS2

Degarelix-d7 TFA-1
Degarelix-d₇ TFA-1 (FE 200486-d₇ TFA-1) is the deuterium labeled Degarelix TFA. Degarelix acetate (FE 200486) is a decapeptide that shows high affinity/selectivity to human gonadotropin-releasing hormone (GnRH) receptor (IC₅₀ = 3 nM). Degarelix acetate Degarelix acetate (FE 200486) is used for the research of prostate cancer.

HY-163263S1

HSD17B13-IN-80-d2	2770247-90-8	98%
HSD17B13-IN-80-d₂ (Compound 200) is the the deuterium labeled HSD17B13-IN-80 (HY-163263). HSD17B13-IN-80 is an inhibitor of hydroxysteroid 17β-dehydrogenase 13 (HSD17B13) with an IC₅₀ value of ≤ 0.1 μM for estradiol. HSD17B13-IN-80 can be used for research on liver diseases, metabolic diseases, or cardiovascular diseases, such as NAFLD or NASH, as well as drug-induced liver injury (DILI).

Name
Email *

	Sorry, but the email address you supplied was invalid.